Charles Schwab’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $325K | Sell |
443,167
-150,331
| -25% | -$110K | ﹤0.01% | 3286 |
|
|
2025
Q1 | $593K | Sell |
593,498
-110,656
| -16% | -$111K | ﹤0.01% | 3020 |
|
|
2024
Q4 | $7.46M | Buy |
704,154
+5,899
| +0.8% | +$62.5K | ﹤0.01% | 2146 |
|
|
2024
Q3 | $9.22M | Buy |
698,255
+406,891
| +140% | +$5.38M | ﹤0.01% | 2063 |
|
|
2024
Q2 | $2.86M | Buy |
291,364
+166,822
| +134% | +$1.64M | ﹤0.01% | 2580 |
|
|
2024
Q1 | $1.71M | Sell |
124,542
-5,370
| -4% | -$73.8K | ﹤0.01% | 2638 |
|
|
2023
Q4 | $2.22M | Buy |
+129,912
| New | +$2.22M | ﹤0.01% | 2583 |
|